AC Immune
ACIU
53 hedge funds and large institutions have $101M invested in AC Immune in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 5 closing their positions.
220% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 5
177% more call options, than puts
Call options by funds: $2.19M | Put options by funds: $792K
33% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 12
26% more funds holding
Funds holding: 42 → 53 (+11)
0.47% more ownership
Funds ownership: 28.37% → 28.83% (+0.47%)
26% less capital invested
Capital invested by funds: $137M → $101M (-$36.1M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$11.1M |
| 2 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$3.33M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$609K |
| 4 |
Morgan Stanley
New York
|
+$490K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$481K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$10.8M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
-$1.82M |
| 3 |
Millennium Management
New York
|
-$1.74M |
| 4 |
Renaissance Technologies
New York
|
-$975K |
| 5 |
BlackRock
New York
|
-$434K |
ACIU Hedge Fund Activity: Q3 2020 in Review
53 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q3 2020, worth a combined $101M — down 26% from $137M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new ACIU positions and 5 closed out — a net gain of 11 holders — while 16 added to existing stakes and 12 trimmed.
The largest buyer was Avidity Partners Management, opening a new position worth an estimated $11.1M. The largest seller was BVF Inc, cutting an estimated $10.8M.
- 53 institutional investors held AC Immune (ACIU) as of Q3 2020, up from 42 in Q2 2020.
- Funds reported $101M of AC Immune stock for Q3 2020, down 26% quarter-over-quarter.
- 16 funds opened new AC Immune positions in Q3 2020 and 5 closed out, a net change of +11 holders.
- The largest AC Immune buyer in Q3 2020 was Avidity Partners Management, an estimated $11.1M added.
- The largest AC Immune seller in Q3 2020 was BVF Inc, an estimated $10.8M sold.
Based on aggregated 13F filings for Q3 2020.